ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma

Tan, Jianlong; Chen, Fengyu; Ouyang, Bin; Li, Xiuying; Zhang, Weidong; Gao, Xinglin*广东省人民医院; 南方医科大学; 1
Frontiers in Oncology2022-9-15DOI: 10.3389/fonc.2022.865756
3被引5阅读
引用收藏
分享

摘要

BackgroundBecause of the high incidence and poor prognoses of lung adenocarcinoma (LUAD), it is essential to identify cost-effective treatment options and accurate and reliable prognostic biomarkers. CDCA4 upregulation has been identified in many cancers. However, the prognostic importance of CDCA4 and its role in LUAD remain unknown. MethodsCDCA4 expression was assessed through IHC, Western blotting (WB) and RT-PCR. The Cancer Genome Atlas (TCGA) provided data from 513 patients to study the expression and prognostic relevance of CDCA4 in LUAD. This study used gene set enrichment analyses (GSEA), gene ontology and KEGG pathway analyses for elucidating potential mechanisms underpinning the function of CDCA4 in LUAD. We also investigated correlations between immune infiltration and CDCA4 expression with single specimen GSEA (ssGSEA). ResultsAccording to database analysis and identification of patient tissue samples, CDCA4 expression in tumour tissues surpassed that in normal tissues (P< 0.001). Increased CDCA4 expression was positively correlated with a higher T, N, pathologic stage and poor primary therapy outcome. In addition, the Kaplan-Meier plotter exhibited that an elevated CDCA4 expression was related to worse disease-specific survival(DSS) and overall survival (OS) (DSS HR= 5.145, 95% CI=3.413-7.758, P<0.001; OS HR=3.570, 95% CI=2.472-5.155, P<0.001). Then multivariate COX regression analyses indicated that the CDCA4 gene was an independent risk consideration for prognoses. GO and KEGG results showed that CDCA4 and its neighbouring genes were enriched in the cell cycle and DNA replication. As determined by GSEA, CDCA4 was related to various immune-related signalling pathways (SPs), Homologous recombination, DNA replication and the cell cycle. SsGSEA analysis showed a significant association between CDCA4 expression and Th2 cells, mast cells, eosinophils and Th17 cells. ConclusionsCDCA4 expression is increased in LUAD and is a potential predictive biomarker and therapeutic target.

学科与关键词

关键词
CDCA4lung adenocarcinomabiomarkerprognosisTCGA
相关
加载中…
  • Implications of different cell death patterns for prognosis and immunity in lung adenocarcinoma
    Zhou, Yang; Gao, Weitong; Xu, Yu; Wang, Jiale; Wang, Xueying; Shan, Liying; Du, Lijuan; Sun, Qingyu; Li, Hongyan; Liu, Fang*npj Precision Oncology, 2023, 7(1): 121.
  • Prognostic value of Holliday junction-recognizing protein and its correlation with immune infiltrates in lung adenocarcinoma
    Chen, Long; Zeng, Chong; Yan, Limei; Liao, Wanyu; Zhen, Chen; Yao, Jie*Oncology Letters, 2022, 24(1): 232.被引 3
  • CD8+ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung Adenocarcinoma
    Zhang, Minghui; Ma, Jianli; Guo, Qiuyue; Ding, Shuang; Wang, Yan; Pu, Haihong*Frontiers in Immunology, 2022, 13: 806877.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-09-15
卷期
第 12 卷
页码
865756
DOI
10.3389/fonc.2022.865756
期刊等级
3区
成果收录
SCIE
资助标注
Hunan Provincial Health Commission; Hunan Provincial People's Hospital; Science and Technology Planning Project of Guangdong Province; [202203023386]; [201911]; [2017A070701014]

作者

  • T

    Tan, Jianlong (第一作者)

    guangdong prov peoples hosp · 2 · southern med univ

  • C

    Chen, Fengyu

    1 · hunan normal univ · hunan prov peoples hosp

查看全部 6 位作者收起作者
  • O

    Ouyang, Bin

    1 · hunan normal univ · hunan prov peoples hosp

  • L

    Li, Xiuying

    1 · hunan normal univ · hunan prov peoples hosp

  • Z

    Zhang, Weidong

    1 · hunan normal univ · hunan prov peoples hosp

  • G

    Gao, Xinglin (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417